About Medsyn Biopharma
Medsyn Biopharma is a private company based in Northville, Michigan. It has reported $19,589,999 raised in three offerings on Form D since March 2023.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Oct 20, 2025 | Nov 4, 2025 | $11,499,999of $11.5M target | 16 | $718K | EquityRule 506(b) | Form D ↗ |
| Jul 31, 2024 | Aug 15, 2024 | $5,000,000fully sold | 5 | $1.0M | EquityRule 506(b) | Form D ↗ |
| Feb 9, 2023 | Mar 3, 2023 | $3,090,000fully sold | 6 | $515K | EquityRule 506(b) | Form D ↗ |
| Total, three offerings | $19,589,999 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Medsyn Biopharma's Form D filed Nov 4, 2025.
MM
Martin Matthew
Executive officer
BW
Brian Wood
Executive officer
JS
John Sorensen
President and director
SW
Shaomeng Wang
Director
Earlier filings also listed Mel John (executive officer and director, last listed Mar 2023) and Gilbert Omenn (director, last listed Mar 2023).